FrancophonIA/ELRC3.0 huggingface dataset:
English: Trials of combination therapy with NPH insulin or thiazolidinediones have been performed.
Croatian: Provedena su ispitivanja u kombiniranoj terapiji s NPH inzulinom ili tiazolidindionima.
English: Plasma repaglinide levels decreased rapidly, and low concentrations were seen in the plasma of Type 2 diabetic patients 4 hours post-administration.
Croatian: Razina repaglinida u plazmi je naglo pala te je u plazmi bolesnika sa šećernom bolešću tipa 2 izmjerena niska koncentracija 4 sata nakon njegove primjene.
English: Each tablet contains 0.5 mg, 1 mg, 2 mg repaglinide.
Croatian: Jedna tableta sadrži 0,5 mg, 1 mg, 2 mg repaglinida.
English: If concomitant use is necessary, careful monitoring of blood glucose and close clinical monitoring should be performed.
Croatian: Ako je neophodna istodobna primjena, potrebno je pažljivo pratiti razinu glukoze u krvi i provoditi poman klinički nadzor.
English: The amount of Enyglid, food or exercise may need to be adjusted.
Croatian: Možda će biti potrebno uskladiti dozu Enyglida, prehranu ili tjelovježbu.
English: Co-administration of cimetidine, nifedipine, oestrogen, or simvastatin with repaglinide, all CYP3A4 substrates, did not significantly alter the pharmacokinetic parameters of repaglinide.
Croatian: Istodobna primjena supstrata CYP3A4 enzima, kao što su cimetidin, nifedipin, estrogen ili simvastatin, s repaglinidom nije značajno izmijenila farmakokinetičke parametre repaglinida.
English: • The other ingredients are: microcrystalline cellulose (E460); calcium hydrogen phosphate, anhydrous; croscarmellose sodium; povidone K25; glycerol; magnesium stearate; meglumine; poloxamer; yellow iron oxide (E172) only in the 1 mg tablets and red iron oxide (E172) only in the 2 mg tablets
Croatian: - Drugi sastojci su mikrokristalična celuloza (E460); bezvodni kalcijev hidrogenfosfat; umrežena karmelozanatrij; povidon K25; glicerol; magnezijev stearat; meglumin; poloksamer; žuti željezov oksid (E172) samo kod tableta od 1 mg i crveni željezov oksid (E172) samo kod tableta od 2 mg.
English: • Clopidogrel (prevents blood clots)
Croatian: - Klopidogrel (sprječava zgrušavanje krvi).
English: • If you have any further questions, ask your doctor or pharmacist.
Croatian: - Ako imate dodatnih pitanja, obratite se svom liječniku ili ljekarniku.
English: Repaglinide can be given in combination with metformin, when the blood glucose is insufficiently controlled with metformin alone.
Croatian: Repaglinid se može davati u kombinaciji s metforminom ako se primjenom samog metformina ne postiže dobra regulacija glukoze u krvi.
English: Repaglinide closes ATP-dependent potassium channels in the β-cell membrane via a target protein different from other secretagogues.
Croatian: Repaglinid zatvara o ATP-u ovisne kalijeve kanale u membrani β-stanica vezanjem za protein koji je različit od proteina na koji se vezuju drugi lijekovi koji potiču izlučivanje inzulina.
English: • Sympathomimetics (used to treat asthma).
Croatian: - Simpatomimetike (za liječenje astme).
English: How to take Enyglid
Croatian: Kako uzimati Enyglid
English: Talk to your doctor before taking Enyglid:
Croatian: Obratite se svom liječniku prije nego uzmete Enyglid: - Ako imate problema s jetrom.
English: Name and address of the manufacturer responsible for batch release
Croatian: Naziv i adresa proizvođača odgovornih za puštanje serije lijeka u promet
English: When these medications are administered to or withdrawn from a patient receiving repaglinide, the patient should be observed closely for changes in glycaemic control.
Croatian: Kad bolesnik koji uzima repaglinid započne s uzimanjem ili prestane uzimati gore navedene lijekove, potrebno je pomno pratiti promjene regulacije glikemije u bolesnika.
English: Dosage adjustment of these compounds when co-administered with repaglinide is therefore not necessary.
Croatian: Stoga nije neophodna prilagodba doze ovih lijekova pri istodobnoj primjeni s repaglinidom.
English: A dose-dependent decrease in blood glucose was demonstrated in Type 2 diabetic patients when administered in doses from 0.5 to 4 mg repaglinide.
Croatian: U bolesnika sa šećernom bolešću tipa 2, sniženje razine glukoze u krvi ovisno o dozi lijeka potvrđeno je pri dozama repaglinida od 0,5 do 4 mg.
English: If concomitant use is necessary, careful monitoring of blood glucose and close clinical monitoring should be performed (see section 4.4).
Croatian: Ako je istodobna primjena neophodna, potrebno je pažljivo pratiti razinu glukoze u krvi i provoditi poman klinički nadzor (vidjeti dio 4.4).
English: The recommended maximum single dose is 4 mg taken with main meals.
Croatian: Preporučena maksimalna pojedinačna doza koja se uzima s glavnim obrocima iznosi 4 mg.
English: Enyglid is not recommended in patients with moderate liver disease.
Croatian: Enyglid se ne preporučuje u bolesnika koji imaju srednje tešku bolest jetre.
English: Your ability to drive or use a machine may be affected if your blood sugar is low or high.
Croatian: Ako je razina šećera u krvi niska ili visoka to može utjecati na sposobnost vožnje ili rukovanja strojem.
English: Co-administration of 200 mg ketoconazole increased the repaglinide (AUC and Cmax) by 1.2-fold with profiles of blood glucose concentrations altered by less than 8% when administered concomitantly (a single dose of 4 mg repaglinide).
Croatian: Istodobna primjena 200 mg ketokonazola povećala je AUC i Cmax repaglinida 1,2 puta uz profile koncentracije glukoze u krvi izmijenjene za manje od 8% pri istodobnoj primjeni (pojedinačna doza repaglinida 4 mg).
English: Repaglinide is almost completely metabolised, and no metabolites with clinically relevant hypoglycaemic effect have been identified.
Croatian: Nije identificiran niti jedan metabolit s klinički značajnim hipoglikemijskim učinkom.
English: Marketing Authorisation Holder KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Croatian: Nositelj odobrenja za stavljanje lijeka u promet KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija
English: Hepatic impairment No clinical studies have been conducted in patients with hepatic insufficiency.
Croatian: Oštećenje funkcije jetre Nisu provedena klinička ispitivanja u bolesnika s insuficijencijom jetre.
English: Enyglid can also be given with metformin, another medicine for diabetes.
Croatian: Enyglid se može primjenjivati i s metforminom, jop jednim lijekom za šećernu bolest.
English: Since the interaction has not been established with dosages higher than 0.5 mg for repaglinide, the concomitant use of deferasirox with repaglinide should be avoided.
Croatian: Budući da interakcije nisu bile utvrđene s dozama repaglinida većim od 0,5 mg, istodobnu primjenu deferasiroksa i repaglinida treba izbjegavati.
English: If the combination appears necessary, careful clinical and blood glucose monitoring should be performed (see section 4.4).
Croatian: Ako je primjena ove kombinacije neophodna, potrebno je pažljivo provoditi klinički nadzor i pratiti razinu glukoze u krvi (vidjeti dio 4.4).
English: • if you take other medicines or suffer from liver or kidney problems (see other sections of 2.
Croatian: To se može dogoditi: - ako uzmete previše Enyglida - ako vježbate više nego obično - ako uzimate druge lijekove ili imate problema s jetrom ili bubrezima (vidjeti druge dijelove podnaslova 2.
English: The AUC (SD) after 2 mg single dose exposure (4 mg in patients with hepatic insufficiency) was 31.4 ng/ml x hr (28.3) in healthy volunteers, 304.9 ng/ml x hr (228.0) in patients with hepatic insufficiency, and 117.9 ng/ml x hr (83.8) in the elderly type 2 diabetic patients.
Croatian: Izloženost repaglinidu povećana je u bolesnika s insuficijencijom jetre te u starijih bolesnika sa šećernom bolešću tipa 2. AUC (SD) nakon primjene pojedinačne doze od 2 mg (4 mg u bolesnika s insuficijencijom jetre) bila je 31,4 ng/ml x sati (28,3) u zdravih dobrovoljaca, 304,9 ng/ml x sati (228,0) u bolesnika s insufijencijom jetre, a 117,9 ng/ml x sati (83,8) u starijih bolesnika sa šećernom bolešću tipa 2.
English: Abnormal hepatic function, increased liver enzymes Isolated cases of increased liver enzymes have been reported during treatment with repaglinide.
Croatian: Tijekom liječenja repaglinidom zabilježeni su pojedinačni slučajevi porasta jetrenih enzima.
English: Since the interaction has not been established with dosages higher than 0.25 mg for repaglinide, the concomitant use of ciclosporin with repaglinide should be avoided.
Croatian: Budući da interakcija nije utvrđena pri dozama repaglinida većim od 0,25 mg, istodobnu primjenu ciklosporina i repaglinida treba izbjegavati.
English: Hypersensitivity reactions of the skin may occur as erythema, itching, rashes and urticaria.
Croatian: Na koži se mogu pojaviti reakcije preosjetljivosti poput eritema, svrbeža, osipa i urtikarije.
English: Repaglinide had no clinically relevant effect on the pharmacokinetic properties of digoxin, theophylline or warfarin at steady state, when administered to healthy volunteers.
Croatian: Pri primjeni u zdravih dobrovoljaca, repaglinid nije imao klinički značajan učinak na farmakokinetička svojstva digoksina, teofilina ili varfarina u stanju dinamičke ravnoteže.
English: In an interaction study with healthy volunteers, co-administration of deferasirox (30 mg/kg/day, 4 days), a moderate inhibitor of CYP2C8 and CYP3A4, and repaglinide (single dose, 0.5 mg) resulted in an increase in repaglinide systemic exposure (AUC) to 2.3-fold (90% CI [2.03-2.63]) of control, a 1.6-fold (90% CI [1.42-1.84]) increase in Cmax, and a small, significant decrease in blood glucose values.
Croatian: U ispitivanju interakcija u zdravih dobrovoljaca, istodobna primjena deferasiroksa (30 mg/kg/dan, 4 dana), umjerenog inhibitora CYP2C8 i CYP3A4 i repaglinida (pojedinačne doze od 0,5 mg) rezultirala je povećanjem sistemske izloženosti repaglinidu (AUC) za 2,3 puta (90% CI [2,03-2,63]) u odnosu na kontrolnu skupinu, povećanjem Cmax za 1,6 puta (90% CI [1,42-1,84]) i malim, ali značajnim sniženjem razine glukoze u krvi.
English: Repaglinide, like other insulin secretagogues, is capable of producing hypoglycaemia.
Croatian: Repaglinid, kao i drugi lijekovi koji potiču izlučivanje inzulina, može izazvati hipoglikemiju.
English: Enyglid 0.5 mg tablets Enyglid 1 mg tablets Enyglid 2 mg tablets
Croatian: Enyglid 0,5 mg tablete Enyglid 1 mg tablete Enyglid 2 mg tablete
English: Hypoglycaemic coma and hypoglycaemic unconsciousness
Croatian: Hipoglikemijska koma i nesvjestica uzrokovana hipoglikemijom
English: Each tablet contains 0.5 mg repaglinide.
Croatian: Svaka tableta sadrži 0,5 mg repaglinida.
English: • Thyroid products (used to treat low levels of thyroid hormones).
Croatian: - Hormone štitnjače (za liječenje niskih razina hormona štitnjače).
English: Enyglid 0.5 mg tablets Enyglid 1 mg tablets Enyglid 2 mg tablets Repaglinide
Croatian: Enyglid 0,5 mg tablete Enyglid 1 mg tablete Enyglid 2 mg tablete repaglinid
English: What Enyglid contains
Croatian: Kako Enyglid izgleda i sadržaj pakiranja
English: After a 5 day treatment of repaglinide (2 mg x 3/day) in patients with a severe impaired renal function (creatinine clearance: 20-39 ml/min.
Croatian: Nakon petodnevnoga liječenja repaglinidom (2 mg x 3/dan) u bolesnika s jako oštećenom bubrežnom funkcijom (klirens kreatinina: 20-39 ml/min), rezultati su pokazali značajno dvostruko povećanje izloženosti (AUC) i poluvijeka (t1/2) u usporedbi s bolesnicima s normalnom bubrežnom funkcijom.
English: In a study conducted in healthy volunteers, the concomitant administration of repaglinide (a single dose of 0.25 mg) and ciclosporin (repeated dose at 100 mg) increased repaglinide AUC and Cmax about 2.5-fold and 1.8-fold respectively.
Croatian: U ispitivanju provedenom na zdravim dobrovoljcima, istodobna primjena repaglinida (pojedinačne doze od 0,25 mg) i ciklosporina (ponavljane doze od 100 mg) povećala je AUC repaglinida otprilike 2,5 puta i Cmax otprilike 1,8 puta.
English: How to store Enyglid
Croatian: Kako čuvati Enyglid
English: The tablets are white, round and biconvex with bevelled edges.
Croatian: Tablete su bijele, okrugle i bikonveksne s ukošenim rubovima.
English: Enyglid 1 mg tablets
Croatian: Enyglid 1 mg tablete
English: • if you have liver problems.
Croatian: - Ako imate problema s bubrezima.
English: The peak plasma level occurs within one hour post administration.
Croatian: Maksimalna koncentracija u plazmi izmjerena je unutar jednog sata nakon primjene.
English: Co-administration of trimethoprim (160 mg twice daily), a moderate CYP2C8 inhibitor, and repaglinide (a single dose of 0.25 mg) increased the repaglinide AUC, Cmax and t½ (1.6-fold, 1.4-fold and 1.2-fold respectively) with no statistically significant effects on the blood glucose levels.
Croatian: Istodobna primjena trimetoprima (160 mg dva puta dnevno), umjerenog inhibitora CYP2C8 i repaglinida (pojedinačna doza od 0,25 mg) povećava AUC, Cmax i t1/2 repaglinida (1,6 puta, 1,4 puta odnosno 1,2 puta) bez statistički značajnog učinka na razinu glukoze u krvi.
English: Patients receiving other oral hypoglycaemic medicinal products Patients can be transferred directly from other oral hypoglycaemic medicinal products to repaglinide.
Croatian: Bolesnici mogu izravno prijeći na repaglinid s nekog drugog oralnog antidijabetika.
English: A number of medicinal products are known to influence repaglinide metabolism, possible interactions should therefore be taken into account by the physician:
Croatian: Stoga liječnik mora uzeti u obzir moguće interakcije:
English: You may get a hypo (short for hypoglycaemia) if your blood sugar gets too low.
Croatian: Možete dobiti hipoglikemiju ako je razina šećera u krvi preniska.
English: Enyglid 2 mg tablets
Croatian: Enyglid 2 mg tablete
English: Enyglid 0.5 mg tablets
Croatian: Enyglid 0,5 mg tablete
English: • if the acid level in your blood is raised (diabetic ketoacidosis).
Croatian: - ako imate šećernu bolest tipa 1. - ako u krvi imate povišenu razinu kiseline (dijabetička ketoacidoza).
English: Enyglid 0.5 mg tablets Each tablet contains 0.5 mg repaglinide.
Croatian: Enyglid 0,5 mg tablete Jedna tableta sadrži 0,5 mg repaglinida.
English: In an interaction study with healthy volunteers, co-administration of clopidogrel (300 mg loading dose), a CYP2C8 inhibitor, increased repaglinide exposure (AUC0-∞) 5.1-fold and continued administration (75 mg daily dose) increased repaglinide exposure (AUC0-∞) 3.9-fold.
Croatian: U ispitivanju interakcija u zdravih dobrovoljaca uz istodobnu primjenu klopidogrela (udarna doza od 300 mg), inhibitora CYP2C8, povećala se izloženost repaglinidu (AUC0-∞) 5,1 puta, a nakon kontinuirane primjene (dnevna doza od 75 mg) povećala se izloženost repaglinidu (AUC0-∞) 3,9 puta.
English: In an interaction study in healthy volunteers, co-administration of 250 mg clarithromycin, a potent mechanism-based inhibitor of CYP3A4, slightly increased the repaglinide (AUC) by 1.4-fold and Cmax by 1.7-fold and increased the mean incremental AUC of serum insulin by 1.5-fold and the maximum concentration by 1.6-fold.
Croatian: Istodobna primjena 250 mg klaritromicina, snažnog inhibitora CYP3A4, u ispitivanju interakcija provedenom na zdravim dobrovoljcima neznatno je povećala AUC repaglinida 1,4 puta i Cmax 1,7 puta te povećala srednju vrijednost AUC inzulina u serumu 1,5 puta i maksimalnu koncentraciju 1,6 puta.
English: Repaglinide should not be used in breast-feeding women.
Croatian: Dojilje ne smiju uzimati repaglinid.
English: Refraction disorders
Croatian: Poremećaji refrakcije
English: Half-life was prolonged from 1.3 hr to 3.7 hr, resulting in possibly enhanced and prolonged blood glucose-lowering effect of repaglinide, and plasma repaglinide concentration at 7 hr was increased 28.6-fold by gemfibrozil.
Croatian: Poluvijek je produljen sa 1,3 na 3,7 sati, rezultirajući mogućim pojačanim i produljenim učinkom repaglinida na snižavanje razine glukoze u krvi.
English: Co-administration of gemfibrozil (600 mg twice daily), an inhibitor of CYP2C8, and repaglinide (a single dose of 0.25 mg) increased the repaglinide AUC 8.1-fold and Cmax 2.4-fold in healthy volunteers.
Croatian: Istodobna primjena gemfibrozila (600 mg dva puta dnevno), inhibitora CYP2C8 i repaglinida (pojedinačne doze od 0,25 mg) u zdravih dobrovoljaca povećava AUC repaglinida 8,1 puta i Cmax 2,4 puta.
English: Clinical data in healthy volunteers support CYP2C8 as being the most important enzyme involved in repaglinide metabolism with CYP3A4 playing a minor role, but the relative contribution of CYP3A4 can be increased if CYP2C8 is inhibited.
Croatian: CYP3A4 ima manju ulogu, ali relativni doprinos CYP3A4 može biti povećan ako je CYP2C8 inhibiran.
English: Each tablet contains 2 mg repaglinide.
Croatian: Svaka tableta sadrži 2 mg repaglinida.
English: STATEMENT OF ACTIVE SUBSTANCE
Croatian: POPIS POMOĆNIH TVARI
English: Your body's response to Enyglid may change if you take other medicines, especially these:
Croatian: Reakcija tijela na Enyglid može se promijeniti ako uzimate druge lijekove, osobito ove: - Inhibitore monoaminooksidaze (MAOI) (za liječenje depresije).
English: Each tablet contains 1 mg repaglinide.
Croatian: Svaka tableta sadrži 1 mg repaglinida.
English: • if you take gemfibrozil (a medicine used to lower increased fat levels in the blood).
Croatian: - Gemfibrozil (za snižavanje povišenih razina masnoća u krvi).
English: Abdominal pain, diarrhoea Common Vomiting, constipation
Croatian: Rijetko Poremećaji probavnog sustava Bol u abdomenu, proljev Često Povraćanje, konstipacija Vrlo rijetko Mučnina
English: Please ask your doctor whether you can drive a car if you:
Croatian: Upitajte svog liječnika smijete li upravljati vozilom ako: - imate česte hipoglikemije, - imate malo znakova hipoglikemije ili oni izostaju.
English: You should not take Enyglid if you are breast-feeding.
Croatian: Ne smijete uzimati Enyglid ako dojite.
English: • ACE-inhibitors (used to treat heart conditions).
Croatian: - ACE inhibitore (za liječenje bolesti srca).
English: Enyglid is used to control type 2 diabetes in adults as an add-on to diet and exercise: treatment is usually started if diet, exercise and weight reduction alone have not been able to control (or lower) your blood sugar.
Croatian: S liječenjem se obično započinje kada se samo dijetom, tjelovježbom i smanjenjem tjelesne težine ne može postići zadovoljavajuća regulacija (ili snižavanje) razine šećera u krvi.
English: Talk to your doctor if any of the above applies to you.
Croatian: Ako se bilo što od gore navedenog odnosi na Vas, obratite se svom liječniku.
English: At such times diabetic control may be lost.
Croatian: U tim se slučajevima može poremetiti regulacija šećerne bolesti.
English: • Hypersensitivity (such as rash, itchy skin, redening of the skin, swelling of the skin)
Croatian: Ne poznata (učestalost se ne može procijeniti iz dostupnih podataka): - Preosjetljivost (kao što je osip, svrbež kože, crvenilo kože, oticanje kože) - Mučnina.
English: OUTER CARTON
Croatian: VANJSKO PAKIRANJE
English: Trials investigating the combination with other insulin secretagogues have not been performed.
Croatian: Nisu provedena ispitivanja o kombinaciji repaglinida s drugim lijekovima koji potiču izlučivanje inzulina.
English: • St.John's wort (herbal medicine).
Croatian: - Gospinu travu (biljni lijek).
English: KRKA Magyarország Kereskedelmi Kft. Tel.: + 361 (0) 355 8490
Croatian: Tel.: + 361 (0) 355 8490
English: The recommended starting dose is 0.5 mg. One to two weeks should elapse between titration steps (as determined by blood glucose response).
Croatian: Između svakog koraka titracije doze (na temelju mjerenja razine glukoze u krvi) trebalo bi proći jedan do dva tjedna.
English: Yellow iron oxide (E172) - only in 1 mg tablets Red iron oxide (E172) - only in 2 mg tablets
Croatian: 6.1 Popis pomoćnih tvari celuloza, mikrokristalična (E460) kalcijev hidrogenfosfat, bezvodni karmelozanatrij, umrežena povidon K25 glicerol magnezijev stearat meglumin poloksamer željezov oksid, žuti (E172) - samo u tabletama od 1 mg željezov oksid, crveni (E172) - samo u tabletama od 2 mg
English: E.J.
Croatian: C.
English: • The active substance is repaglinide.
Croatian: Što Enyglid sadrži - Djelatna tvar je repaglinid.
English: The 2 mg tablets are pink, marbled, round, biconvex with bevelled edges and possible darker spots.
Croatian: Tablete od 2 mg su ružičaste, mramorirane, okrugle, bikonveksne s ukošenim rubovima i mogu imati tamnije točke.
English: Enyglid 2 mg tablets 30 tablets: EU/1/09/580/013 60 tablets: EU/1/09/580/014 90 tablets: EU/1/09/580/015 120 tablets: EU/1/09/580/016 180 tablets: EU/1/09/580/021 270 tablets: EU/1/09/580/017 360 tablets: EU/1/09/580/018
Croatian: Enyglid 2 mg tablete 30 tableta: EU/1/09/580/013 60 tableta: EU/1/09/580/014 90 tableta: EU/1/09/580/015 120 tableta: EU/1/09/580/016 180 tableta: EU/1/09/580/021 270 tableta: EU/1/09/580/017 360 tableta: EU/1/09/580/018
English: 60 tablets: EU/1/09/580/014
Croatian: 60 tableta: EU/1/09/580/014
English: Enyglid 1 mg tablets 30 tablets: EU/1/09/580/007 60 tablets: EU/1/09/580/008 90 tablets: EU/1/09/580/009 120 tablets: EU/1/09/580/010 180 tablets: EU/1/09/580/020 270 tablets: EU/1/09/580/011 360 tablets: EU/1/09/580/012
Croatian: Enyglid 1 mg tablete 30 tableta: EU/1/09/580/007 60 tableta: EU/1/09/580/008 90 tableta: EU/1/09/580/009 120 tableta: EU/1/09/580/010 180 tableta: EU/1/09/580/020 270 tableta: EU/1/09/580/011 360 tableta: EU/1/09/580/012
English: 30 tablets: EU/1/09/580/013
Croatian: 30 tableta: EU/1/09/580/013
English: Meglumine
Croatian: Doziranje
English: What Enyglid looks like and contents of the pack The 0.5 mg tablets are white, round and biconvex with bevelled edges.
Croatian: Tablete od 0,5 mg su bijele, okrugle i bikonveksne s ukošenim rubovima.
English: 90 tablets: EU/1/09/580/015
Croatian: 90 tableta: EU/1/09/580/015
English: The 1 mg tablets are pale brown-yellow, round, biconvex with bevelled edges and possible darker spots.
Croatian: Tablete od 1 mg su blijedo smeđe-žute boje, okrugle, bikonveksne s ukošenim rubovima i mogu imati tamnije točke.
English: 120 tablets: EU/1/09/580/004 180 tablets: EU/1/09/580/019 270 tablets: EU/1/09/580/005 360 tablets: EU/1/09/580/006
Croatian: 120 tableta: EU/1/09/580/004 180 tableta: EU/1/09/580/019 270 tableta: EU/1/09/580/005 360 tableta: EU/1/09/580/006
English: 30 tablets: EU/1/09/580/007
Croatian: 30 tableta: EU/1/09/580/007
English: 120 tablets: EU/1/09/580/016 180 tablets: EU/1/09/580/021 270 tablets: EU/1/09/580/017 360 tablets: EU/1/09/580/018
Croatian: 120 tableta: EU/1/09/580/016 180 tableta: EU/1/09/580/021 270 tableta: EU/1/09/580/017 360 tableta: EU/1/09/580/018
English: 120 tablets: EU/1/09/580/010 180 tablets: EU/1/09/580/020 270 tablets: EU/1/09/580/011 360 tablets: EU/1/09/580/012
Croatian: 120 tableta: EU/1/09/580/010 180 tableta: EU/1/09/580/020 270 tableta: EU/1/09/580/011 360 tableta: EU/1/09/580/012
English: Immune system disorders
Croatian: Poremećaji imunološkog sustava Alergijske reakcije*
English: 60 tablets: EU/1/09/580/002
Croatian: 60 tableta: EU/1/09/580/002
English: 30 tablets: EU/1/09/580/001
Croatian: 30 tableta: EU/1/09/580/001
English: 60 tablets: EU/1/09/580/008
Croatian: 60 tableta: EU/1/09/580/008
English: 90 tablets: EU/1/09/580/003
Croatian: 90 tableta: EU/1/09/580/003
English: PHARMACEUTICAL FORM
Croatian: NAČIN IZDAVANJA LIJEKA
English: 90 tablets: EU/1/09/580/009
Croatian: 90 tableta: EU/1/09/580/009
English: If you get any side effects, talk to your doctor or pharmacist.
Croatian: Ako primijetite bilo koju nuspojavu potrebno je obavijestiti liječnika ili ljekarnika.
English: Adjustment of dose and adherence to diet and exercise should be assessed before classifying a patient as a secondary failure.
Croatian: Prije klasificiranja stanja kao sekundarno zatajivanje treba procijeniti da li je doza koju bolesnik uzima ispravna i da li se pridržava dijete i tjelovježbe.
English: Common (may affect up to 1 in 10 people):
Croatian: Često (mogu se javiti u do 1 na 10 osoba): - bol u trbuhu - proljev